Holen Sie sich die Stockscreener-App
2.255
6.43%
-0.155
Finanzdaten der Zentalis Pharmaceuticals Inc-Aktie (ZNTL)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
17.27%
44.39
|
37.85 | 37.39 | 33.73 | 36.06 |
| Operating Income/Loss |
17.27%
-44.39
|
-37.85 | -37.39 | -33.73 | -36.06 |
| Income/Loss From Continuing Operations Before Tax |
19.63%
-42.15
|
-35.23 | -34.77 | -26.69 | -26.87 |
| Income Tax Expense/Benefit |
15.00%
0.138
|
0.12 | 0.442 | - | - |
| Net Income/Loss |
19.61%
-42.29
|
-35.35 | -35.22 | -26.69 | -26.87 |
| Basic Average Shares |
1.51%
71.33
|
70.26 | - | 72.14 | 71.99 |
| Diluted Average Shares |
1.51%
71.33
|
70.26 | - | 72.14 | 71.99 |
| Basic Earnings Per Share |
18.00%
-0.59
|
-0.50 | - | -0.37 | -0.37 |
| Diluted Earnings Per Share |
18.00%
-0.59
|
-0.50 | - | -0.37 | -0.37 |
0.62%
0.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):